Oct 26, 2016 12:03 pm UTC| Business
SAN JOSE, Calif., Oct. 26, 2016 -- Apigee Corporation (NASDAQ:APIC) today announced that regulatory clearance of the proposed acquisition of Apigee by Google Inc. was obtained from antitrust authorities in Germany on...
Oct 26, 2016 12:03 pm UTC| Business
SAN JOSE, Calif., Oct. 26, 2016 -- Apigee Corporation (NASDAQ:APIC) today announced that regulatory clearance of the proposed acquisition of Apigee by Google Inc. was obtained from antitrust authorities in Germany on...
VCA Inc. Reports Third Quarter 2016 Results and Re-Affirms Financial Guidance for 2016
Oct 26, 2016 12:03 pm UTC| Business
Revenue increased 19.1% to a third quarter record of $656.9 millionGross profit increased 13.7% to $156.6 millionOperating income increased 10.2% to $107.0 millionDiluted earnings per common share increased 6.0% to...
Oct 26, 2016 12:03 pm UTC| Business
NEW YORK, Oct. 26, 2016 -- Faruqi Faruqi, LLP, a leading national securities law firm, reminds investors in Biogen Inc. (“Biogen” or the “Company”) (Nasdaq:BIIB) of the December 23, 2016 deadline to seek the role of...
Oct 26, 2016 12:03 pm UTC| Business
NEW YORK, Oct. 26, 2016 -- Faruqi Faruqi, LLP, a leading national securities law firm, reminds investors in Biogen Inc. (“Biogen” or the “Company”) (Nasdaq:BIIB) of the December 23, 2016 deadline to seek the role of...
Oct 26, 2016 12:02 pm UTC| Business
First Immunotherapeutic Candidate to Leverage Selecta’s Proprietary Synthetic Vaccine Particle (SVP™) PlatformSEL-212 Targeting Unmet Needs of Chronic Refractory and Tophaceous Gout PatientsInitial Phase 2 Trial Results...
Oct 26, 2016 12:02 pm UTC| Business
First Immunotherapeutic Candidate to Leverage Selecta’s Proprietary Synthetic Vaccine Particle (SVP™) PlatformSEL-212 Targeting Unmet Needs of Chronic Refractory and Tophaceous Gout PatientsInitial Phase 2 Trial Results...